336 related articles for article (PubMed ID: 28725977)
1. The effect of vitamin D and calcium supplementation in pediatric steroid-sensitive nephrotic syndrome.
Banerjee S; Basu S; Sen A; Sengupta J
Pediatr Nephrol; 2017 Nov; 32(11):2063-2070. PubMed ID: 28725977
[TBL] [Abstract][Full Text] [Related]
2. Effect of two prophylactic bolus vitamin D dosing regimens (1000 IU/day vs. 400 IU/day) on bone mineral content in new-onset and infrequently-relapsing nephrotic syndrome: a randomised clinical trial.
Muske S; Krishnamurthy S; Kamalanathan SK; Rajappa M; Harichandrakumar KT; Sivamurukan P
Paediatr Int Child Health; 2018 Feb; 38(1):23-33. PubMed ID: 28466679
[TBL] [Abstract][Full Text] [Related]
3. Three-monthly bolus vitamin D supplements (1000 vs 400 IU/day) for prevention of bone loss in children with difficult-to-treat nephrotic syndrome: a randomised clinical trial.
Singh DN; Krishnamurthy S; Kamalanathan SK; Harichandrakumar KT; Sivamurukan P
Paediatr Int Child Health; 2018 Nov; 38(4):251-260. PubMed ID: 30092157
[TBL] [Abstract][Full Text] [Related]
4. Calcium and vitamin D for osteoprotection in children with new-onset nephrotic syndrome treated with steroids: a prospective, randomized, controlled, interventional study.
Choudhary S; Agarwal I; Seshadri MS
Pediatr Nephrol; 2014 Jun; 29(6):1025-32. PubMed ID: 24414607
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements.
Gulati S; Sharma RK; Gulati K; Singh U; Srivastava A
Nephrol Dial Transplant; 2005 Aug; 20(8):1598-603. PubMed ID: 15956073
[TBL] [Abstract][Full Text] [Related]
6. Markers of bone metabolism in children with nephrotic syndrome treated with corticosteroids.
Pańczyk-Tomaszewska M; Adamczuk D; Kisiel A; Skrzypczyk P; Przedlacki J; Górska E; Stelmaszczyk-Emmel A; Demkow U; Roszkowska-Blaim M
Adv Exp Med Biol; 2015; 840():21-8. PubMed ID: 25310960
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome.
Bak M; Serdaroglu E; Guclu R
Pediatr Nephrol; 2006 Mar; 21(3):350-4. PubMed ID: 16382319
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral density and vitamin D status in children with remission phase of steroid-sensitive nephrotic syndrome.
Cetin N; Gencler A; Sivrikoz IA
Saudi J Kidney Dis Transpl; 2019; 30(4):853-862. PubMed ID: 31464242
[TBL] [Abstract][Full Text] [Related]
9. The impact of vitamin D supplementation on vitamin D level, urinary calcium excretion and bone density in patients with hypercalciuria and vitamin D deficiency - preliminary report.
Milart J; Jobs K; Tłustochowicz M; Pogonowska M; Kalicki B
Dev Period Med; 2018; 22(2):145-152. PubMed ID: 30056401
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D in incident nephrotic syndrome: a Midwest Pediatric Nephrology Consortium study.
Selewski DT; Chen A; Shatat IF; Pais P; Greenbaum LA; Geier P; Nelson RD; Kiessling SG; Brophy PD; Quiroga A; Seifert ME; Straatmann CE; Mahan JD; Ferris ME; Troost JP; Gipson DS
Pediatr Nephrol; 2016 Mar; 31(3):465-72. PubMed ID: 26498119
[TBL] [Abstract][Full Text] [Related]
11. Bioavailable vitamin D levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndrome.
Aggarwal A; Yadav AK; Ramachandran R; Kumar V; Kumar V; Sachdeva N; Khandelwal N; Jha V
Nephrology (Carlton); 2016 Jun; 21(6):483-9. PubMed ID: 26428957
[TBL] [Abstract][Full Text] [Related]
12. [Dynamics of bone biochemical markers in nephrotic children treated with prednisone and metabolites of vitamin D].
Wojnar J; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
Przegl Lek; 2007; 64(9):552-8. PubMed ID: 18510075
[TBL] [Abstract][Full Text] [Related]
13. Effect of supplementation of calcium and vitamin D on bone mineral density and bone mineral content in peri- and post-menopause women; a double-blind, randomized, controlled trial.
Di Daniele N; Carbonelli MG; Candeloro N; Iacopino L; De Lorenzo A; Andreoli A
Pharmacol Res; 2004 Dec; 50(6):637-41. PubMed ID: 15501704
[TBL] [Abstract][Full Text] [Related]
14. Effect of Calcium and Vitamin D Supplementation (Dairy vs. Pharmacological) on Bone Health of Underprivileged Indian Children and Youth with Type-1 Diabetes: A Randomized Controlled Trial.
Khadilkar A; Oza C; Antani M; Shah N; Lohiya N; Khadilkar V; Bhor S; Kajale N; Gondhalekar K; More C; Katapally TR; Mughal Z; Bhawra J; Padidela R
J Clin Densitom; 2024; 27(2):101468. PubMed ID: 38325238
[TBL] [Abstract][Full Text] [Related]
15. Free vitamin D levels in steroid-sensitive nephrotic syndrome and healthy controls.
Banerjee S; Basu S; Akhtar S; Sinha R; Sen A; Sengupta J
Pediatr Nephrol; 2020 Mar; 35(3):447-454. PubMed ID: 31845055
[TBL] [Abstract][Full Text] [Related]
16. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial of the effects of calcium with or without vitamin D on bone structure and bone-related chemistry in elderly women with vitamin D insufficiency.
Zhu K; Bruce D; Austin N; Devine A; Ebeling PR; Prince RL
J Bone Miner Res; 2008 Aug; 23(8):1343-8. PubMed ID: 18410225
[TBL] [Abstract][Full Text] [Related]
18. Effect of calcium, vitamins K1 and D3 on bone in galactosemia.
Panis B; Vermeer C; van Kroonenburgh MJPG; Nieman FHM; Menheere PPCA; Spaapen LJ; Rubio-Gozalbo ME
Bone; 2006 Nov; 39(5):1123-1129. PubMed ID: 16782422
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D in nephrotic syndrome remission: a case-control study.
Banerjee S; Basu S; Sengupta J
Pediatr Nephrol; 2013 Oct; 28(10):1983-9. PubMed ID: 23708762
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D supplementation in breastfed infants from Montréal, Canada: 25-hydroxyvitamin D and bone health effects from a follow-up study at 3 years of age.
Gallo S; Hazell T; Vanstone CA; Agellon S; Jones G; L'Abbé M; Rodd C; Weiler HA
Osteoporos Int; 2016 Aug; 27(8):2459-66. PubMed ID: 26968165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
